Docoh
Loading...

BIO Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide. Bio-Rad’s life science products primarily include instruments, software, consumables, reagents, and content for the areas of cell biology, gene expression, protein purification, protein quantitation, drug discovery and manufacture, food safety, and science education. These products are based on technologies to separate, purify, identify, analyze, and amplify biological materials such as antibodies, proteins, nucleic acids, cells, and bacteria.

Company profile

Ticker
BIO, BIO.B
Exchange
CEO
Norman Schwartz
Employees
Incorporated
Location
Fiscal year end
Former names
BIO RAD LABORATORIES INC
SEC CIK
IRS number
941381833

BIO stock data

(
)

Calendar

15 Feb 21
18 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 667.12M 667.12M 667.12M 667.12M 667.12M 667.12M
Cash burn (monthly) 59.33M (positive/no burn) (positive/no burn) (positive/no burn) (positive/no burn) (positive/no burn)
Cash used (since last report) 213.89M n/a n/a n/a n/a n/a
Cash remaining 453.23M n/a n/a n/a n/a n/a
Runway (months of cash) 7.6 n/a n/a n/a n/a n/a

Beta Read what these cash burn values mean

My notes
No notes yet
My annotations
No annotations yet
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
8 Apr 21 Daskal Ilan Bio-Rad A Common Stock Payment of exercise Dispose F No No 592.23 250 148.06K 907
8 Apr 21 Daskal Ilan Bio-Rad A Common Stock Option exercise Aquire M No No 0 700 0 1,157
8 Apr 21 Daskal Ilan RSU Bio-Rad A Common Stock Option exercise Dispose M No No 0 700 0 2,100
19 Feb 21 Timothy S Ernst Bio-Rad A Common Stock Sell Dispose S No No 640.17 196.107 125.54K 1,220
19 Feb 21 Timothy S Ernst Bio-Rad A Common Stock Sell Dispose S No No 640.92 327 209.58K 1,416.107
19 Feb 21 Timothy S Ernst Bio-Rad A Common Stock Sell Dispose S No No 640.94 400 256.38K 1,743.107
19 Feb 21 Timothy S Ernst Bio-Rad A Common Stock Option exercise Aquire M No No 159.32 400 63.73K 2,143.107
19 Feb 21 Timothy S Ernst NQSO Bio-Rad A Common Stock Option exercise Dispose M No No 159.32 400 63.73K 850
16 Dec 20 Dara Wright Bio-Rad A Common Stock Payment of exercise Dispose F No No 576.72 174 100.35K 328
16 Dec 20 Dara Wright Bio-Rad A Common Stock Option exercise Aquire M No No 0 502 0 502

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

79.0% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 480 469 +2.3%
Opened positions 75 63 +19.0%
Closed positions 64 54 +18.5%
Increased positions 176 174 +1.1%
Reduced positions 168 172 -2.3%
13F shares
Current Prev Q Change
Total value 11.82B 10.15B +16.4%
Total shares 19.57M 19.04M +2.8%
Total puts 26.4K 28.5K -7.4%
Total calls 22.52K 17.3K +30.2%
Total put/call ratio 1.2 1.6 -28.8%
Largest owners
Shares Value Change
Vanguard 2.27M $1.32B +0.9%
BLK Blackrock 1.89M $1.1B +16.7%
FMR 1.69M $986.48M +20.5%
STT State Street 977.57K $569.87M +2.0%
IVZ Invesco 560.25K $326.59M +21.8%
Ubs Global Asset Management Americas 503.56K $293.54M +30.4%
Brown Advisory 475.67K $277.29M +2.2%
Westfield Capital Management 412.06K $240.21M +38.3%
American Century Companies 405.84K $236.58M -30.7%
Alliancebernstein 387.19K $225.71M +6.5%
Largest transactions
Shares Bought/sold Change
GQG Partners 0 -354.27K EXIT
FMR 1.69M +287.83K +20.5%
BLK Blackrock 1.89M +270.11K +16.7%
Norges Bank 205.18K +205.18K NEW
American Century Companies 405.84K -179.98K -30.7%
Polar Capital 162.99K +162.99K NEW
Atlanta Capital Management Co L L C 241.52K -156.46K -39.3%
POLR Polar Capital 0 -148.27K EXIT
HealthCor Management 140.08K +140.08K NEW
California Public Employees Retirement System 175.95K +127.19K +260.8%

Financial report summary

?
Risks
  • We may incur losses in future periods due to write-downs in the value of financial instruments.
  • A significant majority of our voting stock is held by the Schwartz family, which could lead to conflicts of interest.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: ABO, actuarial, Africa, amplify, appraised, aspect, assumption, automatically, avoid, bankruptcy, burden, capacity, career, carryover, catastrophic, CBER, CDRH, Celsee, child, choice, choose, cleaning, climate, consulting, contemplation, culture, cycle, Defense, demographic, dental, deploy, diminution, discourage, distanced, doctrine, donor, earlier, ease, elder, empowerment, encourage, essential, Facilitation, feasible, fellow, fighting, finite, flight, focused, forum, foster, gender, hazard, headcount, highest, hire, history, inapplicable, interpersonal, intervening, invocation, judicial, lab, leadership, learning, LIBOR, Likewise, literacy, mandated, mitigation, Mug, NaN, onsite, orientation, outlined, overdue, overwhelming, pandemic, physical, prioritize, proceed, proceeding, prudent, quarantine, race, radiation, radioactive, rapid, relocation, remote, remotely, rest, reward, risky, roughly, salary, salvage, sanitation, scale, scaled, setup, sexual, shortened, side, sound, spectral, strong, talent, thereunder, threshold, tied, unforeseen, unique, unknown, unnecessary, vaccine, vast, vision, vital, waived, waste, welfare, workplace
Removed: AbD, acceleration, accrual, acquiree, acquirer, adjoining, alleged, anguish, announcement, appeal, arose, assimilate, authorization, bad, Bay, began, biochemical, Biotest, broadened, burdensome, buyer, cell, certified, Circuit, Codification, collecting, commensurate, complaint, computation, conflict, Congo, consistent, Consumer, consummation, contracted, coordinated, Council, counsel, daily, dedicate, Democratic, denied, deployment, desired, DiaMed, diligence, disadvantage, discrete, dismissal, dissatisfaction, DRC, emerging, emotional, EU, eventual, evolution, excessive, executing, expanded, field, flexibility, formally, formed, Founded, FSB, grouped, harmonize, immunology, inclusion, incurrence, intent, interim, investigated, issuable, kit, lawsuit, leaving, lost, low, lowering, loyalty, mental, mentioned, merged, mined, misleading, motion, Norman, oil, pain, paper, Pasteur, plaintiff, positively, prejudgment, prejudice, prematurely, preserved, produced, profile, promulgate, prospectively, provisional, rank, reconcile, recovery, referendum, reinstatement, relieve, remediate, renewed, repay, Republic, requested, residual, retaliation, revision, Sanford, Sanofi, seller, separation, Serotec, sorting, sought, sourcing, specialty, stage, Stark, Street, sufficiently, suit, superseded, today, tolerable, tolerance, train, trial, Trustee, typing, unconsolidated, validate, vendor, verify, Vice, vulnerability, Wadler, waiting, Wall, warranted, whistleblower, Wilmington, withdraw, wrongful

Patents

GRANT
Utility
System and method for capturing and analyzing cells
13 Apr 21
A system and method for capturing and analyzing a set of cells, comprising: an array including a set of parallel pores, each pore including a chamber including a chamber inlet and a chamber outlet, and configured to hold a single cell, and a pore channel fluidly connected to the chamber outlet; an inlet channel fluidly connected to each chamber inlet of the set of parallel pores; an outlet channel fluidly connected to each pore channel of the set of parallel pores; a set of electrophoresis channels fluidly coupled to the outlet channel, configured to receive a sieving matrix for electrophoretic separation; and a set of electrodes including a first electrode and a second electrode, wherein the set of electrodes is configured to provide an electric field that facilitates electrophoretic analysis of the set of cells.
GRANT
Utility
Mutant DNA polymerases
30 Mar 21
Mutant Type-A DNA polymerases having increased resistance to one or more polymerization activity inhibitors are provided.
GRANT
Utility
Droplet velocity detection
30 Mar 21
Methods and systems are provided for measuring a velocity of a droplet passing through a microfluidic channel.
APP
Utility
Chromatography Resin Having an Anionic Exchange-hydrophobic Mixed Mode Ligand
25 Mar 21
Chromatography resins having mixed mode ligands and methods of using such resins are provided.
APP
Utility
Microfluidic Systems and Methods for Reducing the Exchange of Molecules Between Droplets
25 Mar 21
The present invention generally relates to systems and methods to create stable emulsions with low rates of exchange of molecules between microdroplets.